Will Big Pharma engage in Medicare price negotiations? The verdict's not in
Fierce Pharma
SEPTEMBER 27, 2023
Will Big Pharma engage in Medicare price negotiations? The verdict's not in zbecker Wed, 09/27/2023 - 10:40
Fierce Pharma
SEPTEMBER 27, 2023
Will Big Pharma engage in Medicare price negotiations? The verdict's not in zbecker Wed, 09/27/2023 - 10:40
Fierce Pharma
AUGUST 24, 2023
Royalty Pharma has built a niche by finding innovative products pre- and post-approval from companies that need an infusion of cash in exchange for future royalties. Royalty Pharma has signed a deal with Ferring Pharmaceuticals to collect royalties on bladder cancer drug Adstiladrin.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 8, 2023
Three Japanese pharma companies lead our news stories from Asia this week. Astellas has abandoned its challenge against the Inflation Reduction Act. Astellas has abandoned its challenge against the Inflation Reduction Act. Otsuka bought a Canadian psychedelic biotech.
Fierce Pharma
JUNE 20, 2023
Paired with statins, the once-daily tablet—formulated from the ancient therapy colchicine—has been shown to reduce the risk of stroke and cardiovascular death by 31%.
World of DTC Marketing
AUGUST 15, 2022
The great resignation has not affected pharma because the jobs within the industry pay very well and most positions and employees like the benefit of having a steady job with good money. However, some pharma companies are having problems filling open positions, and when they do, they often find it wasn’t a good fit.
World of DTC Marketing
JULY 28, 2022
Still, the pharma industry is fighting hard to keep it off the table. Pharma is a very profitable industry. The pharma industry has been a solid place to invest money over time. The shame of pharma… The post The continued shame of pharma appeared first on World of DTC Marketing.com.
World of DTC Marketing
JULY 6, 2022
Much has been disclosed over the years about McKinsey’s relationship with Purdue Pharma, including the consulting firm’s recommendation that the drug maker “ turbocharge ” its sales of OxyContin. The post Misjustice benefits pharma appeared first on World of DTC Marketing.com. There is more blame to go around as well.
Let's personalize your content